INTRODUCTION
The majority of active pharmaceutical ingredients (APIs) are small-molecule organic crystals. 1, 2 Crystallization is an essential step in their production, wherein the form (i.e. polymorph), crystal morphology, and crystal size impacts processing as well as other important physicochemical properties, including solubility and dissolution rate. [3] [4] [5] Dissolution is the first step in drug absorption from the solid form, and it plays a critical role in drug bioavailability. 6, 7 Crystals are bounded by faces that are truncations of the three-dimensional lattice along specific crystallographic directions. As such, crystallographically unique faces are expected to exhibit different growth and dissolution behavior.
Growth morphologies and kinetics of well-defined crystal faces have been explored using methods such as in situ scanning probe and interferometric microscopies, [8] [9] [10] [11] [12] [13] often providing more insightful and accurate measurements of crystal growth than statistical sampling of bulk crystal morphologies. 14 Likewise, measurements of the dissolution kinetics of crystal suspensions that provide average rates of a population of crystals are common, [15] [16] [17] but measurements of dissolution of individual crystal faces of single crystals are rare. Mass transport conditions in such systems depend on several parameters that are not easily quantified, including type and speed of the stirrer, vessel and baffle geometry, 18, 19 solution density and viscosity, diffusion, crystal morphology, and the quantity and size distribution of the solid particles. 18, 20 Mass transport typically is not well defined, to the extent that deducing the kinetic regime can be difficult. Ideally, experimental studies should be configured to allow quantitative local mass transport, from which local undersaturation at the solid/liquid interface and the relationship between surface structure and reactivity can be obtained. Flow cell techniques overcome some of the limitations, 21, 22 but typically these are limited to large macroscopic sample areas and particular crystal faces.
These approaches often are not ideal for the dissymmetric character of organic crystal surfaces, which typically are decorated with various crystallographically unique faces, edges, corners and defects that contribute differently to the dissolution process (mechanism and rate). In this respect, near-field microscopies are proving valuable for the study of the dissolution of individual crystals, including atomic force microscopy (AFM), [23] [24] [25] [26] optical microscopy, 27, 28 and scanning electrochemical microscopy (SECM). 29 Rapid interfacial dissolution kinetics of crystals have been determined by SECM 30 and scanning electrochemical cell microscopy (SECCM). 31 In situ interferometry 32 can be useful for determining concentration gradients at crystal/solution interfaces by monitoring changes in the refractive index of the solution, although the minimum detectable concentration difference depends on the minimum fringe shift (ca. 10% of the total concentration change in solution) 33 and interferometric data tend to represent the average across the studied area. As such, they usually are not suitable for high resolution measurements of heterogeneous reactivity or concentration gradients.
New approaches for assessing dissolution kinetics are essential for the optimization of drug formulations, particular methodologies that permit facile and quantitative characterization of dissolution at a microscopic level that will fill knowledge gaps at the molecular level. Herein we describe a comprehensive approach to real-time characterization of the dissolution of individual faces of single crystals using optical microscopy, scanning ion-conductance microscopy (SICM) and finite element method modeling. SICM is a powerful non-contact method that makes use of a nanopipette for high resolution topographical imaging, [34] [35] [36] with the potential to map the dissolution behavior of individual topographical features on crystal surfaces. Collectively, these enable determination of concentration gradients, interfacial concentrations, and separation of kinetic and mass transport limiting regimes. This approach is demonstrated here for the API furosemide (Scheme 1), a loop diuretic drug marketed under the brand name Lasix. 37 Furosemide is a weak acid, classified as a BCS Class IV drug because of its low permeability and poor solubility. 38 Consequently, the bioavailability of furosemide from oral dosage is low (60%) and the rate and extent of absorption varies between and within individuals. 39 It is reasonable to suggest that understanding the dissolution kinetics of furosemide crystals at the microscopic level could lead to strategies for improving its bioavailability and its optimum solid-state form. X-ray characterization. Single crystal X-ray diffraction analysis of furosemide was performed using a suitably large crystal of furosemide (>100 μm) that was mounted on a Mitegen loop with silicon oil and placed on an Oxford Diffraction Xcalibur Gemini diffractometer equipped with a Ruby CCD area detector. The crystal temperature was maintained at 150(2) K during data collection. The crystal structure was solved using Olex2 44 with the ShelXS-2013 45 structure solution program using Direct Methods and refined with the XL refinement package using Least Squares minimization. Powder X-ray diffraction measurements were performed using a Panalytical X'Pert Pro MRD equipped with a hybrid monochromator for CuKα1 radiation ( = 1.541 Å). The glass slide on which the furosemide crystals were grown was mounted on the sample holder. A Pixcel detector was used in scanning mode over the range 5° < 2 < 30°, stepping 0.025° over a period of 45 minutes.
Morphology prediction.
To identify the exposed crystal faces, the furosemide crystal morphology was calculated based on the growth morphology method using the Morphology module in Materials Studio (Materials Studio 8.0.100.21, Accelrys, San Diego, CA). The growth morphology method takes into account the energetics of the system and requires the selection of an appropriate forcefield. The geometry of the furosemide unit cell obtained from single crystal CCD X-ray diffraction experiments was optimized using the COMPASS, consistent-valence forcefield (cvff), and Dreiding forcefields and the optimized unit cell with lowest lattice energy and lattice parameters best matching the experimental unit cell was selected for morphology predictions. Geometry optimizations were conducted using the Forcite molecular mechanics tool. The Quasi-Newtown algorithm was used with a convergence tolerance of 2.0  10 Ag/AgCl quasi-reference counter electrode (QRCE) was inserted into the nanopipette and another was submerged in the petri dish bulk solution. The nanopipettes were mounted on a 38 μm -travel range single axis (Z) piezoelectric positioner (P-753-3CD, PhysikInstrumente, Germany) to control the height of the probe and oriented normal to the surface of interest, as previously described. 46 The petri dish containing the furosemide crystals was mounted on a two-axis (XY) piezoelectric positioner system (Nano-BioS300, Mad City Labs Inc., Madison, WI) for lateral positioning. The SICM was operated in bias modulated (BM) mode, 47 in which there was zero net bias between the two QRCEs. A lock-in amplifier (SR830, Stanford Research Systems, Sunnyvale, CA) was used to generate an oscillating bias (38 mV amplitude, 357 Hz frequency) applied to the bulk QRCE, and the resulting current was measured at the QRCE in the nanopipette using a custom-built wideband current-to-voltage converter. The instrument was controlled and data collected with a programmed FPGA card (7852R, National
Instruments, Austin, TX) using LabVIEW (2013, National Instruments, Austin TX).
The experimental configuration for optical and SICM dissolution measurements is illustrated in Figure 1 .
Furosemide crystals, typically with the longest dimension ranging from 30 -60 μm and various lengthwidth-height ratios, were selected. Some crystals were removed to create separations greater than 40
times their largest dimension to ensure high undersaturation (sink conditions) and avoid overlap of diffusion profiles among neighboring crystals. Following addition of 4 mL of a 50 mM aqueous solution of KCl to the Petri dish, time-lapse sequence of optical images (400 magnification, every 30 s) and line traces along the crystal in an SICM hopping mode 48, 49 were acquired. The nanopipette probe was lowered toward the surface at a rate of 1 μm s -1 at each position. When the surface was detected by the probe as a change in the phase of the AC current to a defined set point (typically 0.1° change from the bulk phase value), the z position was recorded and the nanopipette was retracted 5 μm at a rate of 10 μm s -1 , after which it was moved laterally to a new location, typically 3-6 μm from the previous position. This process was then repeated at a minimum of 10 lateral positions, which enabled acquisition of line profile and measurement of crystal height in approximately 60 seconds. Crystal dimensions were determined from the optical microscope images using ImageJ (version 1.45, NIH).
Figure 1.
Optical microscopy-SICM configuration. The SICM system was mounted on an inverted optical microscope for the simultaneous tracing of the dissolution process by optical microscopy and SICM. The petri dish containing the crystals was positioned on the microscope stage and the nanopipette for SICM scans was submerged normal to the surface. Line traces of the local height along the crystal were generated in hopping mode BM-SICM, with the probe scanned forward and backward over the same line along the crystal (right).
Atomic Force Microscopy (AFM). AFM images of furosemide crystals mounted on the glass slide in the
Petri crystallization dish were acquired in air before and after partial dissolution using a BioScope Three-dimensional domain used for FEM simulations (not drawn to scale). The numbers correspond to the boundaries described in Table 1 .
The maximum characteristic diffusional time for mass transport from microscopic surfaces to bulk solution can be estimated using a semi-infinite diffusion model according to equation 1, where tdiff is the steady-state diffusion time, d is crystal largest dimension size and D denotes diffusion coefficient.
(1)
The diffusion coefficient of furosemide was estimated from the Wilke-Chang correlation 50 
The model, denoted here M1, was developed by applying a flux (per unit area) for each crystal face (observed dissolution rate, Obs hkl J ) ( ) measured experimentally. Using the appropriate boundary conditions (Table 1 ) the concentration of furosemide in the solution around the dissolving crystal could be simulated, from which it was possible to distinguish the dissolution regime, i.e., mass transport vs. kinetic control; vide infra. In order to deduce the relative importance of mass transport and surface kinetics, a model (M2) with the same geometry but different boundary conditions was employed ( Table 1 ), such that dissolution was controlled by diffusion (crystal/solution interface saturated). Solution of the partial differential equations for both models (M1 and M2) was achieved using the direct solver MUMPS in the COMSOL environment, with a relative error tolerance of 10 -6 . Simulations were carried out with >7,500,000 tetrahedral mesh elements. The mesh resolution was refined to be the finest, down to a value of 0.1 nm, at the surfaces of the crystal. 
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The boundary numbers are for the planes labeled in Figure 2 n denotes the vector normal to the surface cs is the solubility concentration of furosemide (0.2 mM)
RESULTS AND DISCUSSION
Furosemide crystals. Four polymorphic forms and two solvates of furosemide have been reported previously. 37, 52, 53 The investigation described herein focused on Polymorph I, which is the only polymorph present in the commercial drug. 53 Single crystal CCD X-ray diffraction confirmed that recrystallized furosemide crystals were polymorph I, which crystallizes in the triclinic P-1 space group (see Supporting Information Table S1 ). 37 Powder X-ray diffraction of furosemide crystals grown on a glass slide from ethanol/water solutions supersaturated with furosemide revealed only peaks corresponding to the (00l) reflections (l = 1 -3), confirming that the crystals were oriented with the (001) face parallel to the glass slide (Supporting Information, Figure S1 ). Optical microscopy revealed a raftlike habit with a triclinic morphology ( Figure 3A , B). Crystal morphology prediction can serve as a useful aid in identifying relevant crystal faces when crystal dimensions are less than those required for indexing by X-ray diffraction. Methods for predicting crystal morphology based on crystal structure have become routine and yield crystal morphologies that are consistent with experimental morphologies for a wide range of molecular crystals despite a lack of consideration for the external growth environment. 54 These methods include (i) the Bravais-Friedel Donnay-Harker (BFDH), a geometric calculation based on crystal lattice and symmetry; (ii) the equilibrium method, based on the surface free energies of relevant crystal faces; and (iii) the growth (or "attachment energy") method, based on attachment energies corresponding to relevant crystal faces. The growth method (iii) is most effective when considering only the internal interactions of the crystal structure. [55] [56] The growth method, developed by Hartmann and Perdok, relies on the bond energy released when one building unit is attached to the surface of a crystal face to predict crystal morphology. 57, 58 The growth rate normal to a particular face is proportional to the attachment energy for that surface -large attachment energies (i.e. more negative values) for a specific face correspond to strong out-of-plane intermolecular interactions, corresponding to faster growth normal to the plane and a lower morphological significance for the face.
Three force fields that have been used often for the prediction of organic crystals habits [59] [60] [61] were evaluated for predicting the morphology of furosemide Polymorph I. The molecular geometries and lattice parameters of the furosemide unit cell were optimized using the COMPASS, Dreiding, and cvff forcefields (see Supporting Information Table S2 ). The COMPASS forcefield was chosen for morphology calculations because it provided the lowest lattice energy and the lattice parameters best matched those of the experimental unit cell. The furosemide morphology predicted from the COMPASS forcefield reveals that three crystal faces -(001), (010) and (101) -contribute to 90% of the predicted total area of the crystal (Figure 3C , D; Table 2 ). Crystal faces with a calculated area of <5% were not observed in the experimental morphology, which is not surprising given that experimental crystal habit is strongly affected by many environmental factors, including solvent, supersaturation, pH, and temperature, 59, 62 which are not captured in the morphology prediction calculations. These crystal faces, if present, cannot be studied by the measurements conducted in our experiments and are not addressed here. 49 and hybrid 63 have been used to acquire images of the topography of soft surfaces 36, 64 and for local ion current measurements. [65] [66] [67] Most recently, a new method based on the application of an oscillating bias between both QRCEs to generate an alternating ion current (AC) feedback signal, bias modulated SICM (BM─SICM), 47 has been introduced.
This approach has several advantages over the traditional nanopipette oscillation SICM method, including minimization of perturbations of the local ionic atmosphere and from effects of convection (stirring) and electro-osmosis. Moreover, it offers opportunities for faster imaging. 67 The dissolution rate is expected to be determined by a combination of (i) interfacial (intrinsic) dissolution kinetics, which are governed by energetics of the surface and solvation effects, and (ii) mass transport of dissolved species from the crystal surface to the bulk solution. 18 Consequently, dissolution kinetics reflects a competition between these two processes, with the slowest governing the overall rate, leading to either kinetic (interfacial) control, mass transport (diffusion) control, or a mixed regime where both contributions are comparable. The measurement of intrinsic dissolution kinetics requires the mass transport rates to be comparable to or greater than surface kinetics, which in turn requires that mass transport is well defined and calculable.
The temporal change in the lateral dimensions of furosemide crystals (i.e. the size of the (001) face) was recorded by measurement of the retreat of the {010} and {101} faces using optical microscopy ( Figure   4A ). The changes in crystal height (normal to the (001) face) were obtained by BM-SICM for the (001) face ( Figure 4B, D) . Collectively, these measurements identify the change in crystal size for all three dimensions. The dissolution rate was effectively constant for all three faces during the first ten minutes, but at longer times the dissolution rate increased. The faster dissolution rate was accompanied by surface roughening and the formation of pits on the (001) surface (vide infra), which were evident even in optical images. It is reasonable to suggest that the roughened surfaces and pits would result in higher index microfacets in the crystal surface, leading to enhanced dissolution kinetics ( Figure 4A ). Under these conditions, it is anticipated that crystal dissolution becomes increasingly limited by mass transport. 28, [68] [69] [70] This is consistent with our recent observation of the dissolution kinetics of the (110) face of salicylic acid in aqueous solution using hopping intermittent contact-scanning electrochemical microscopy, 70 where we found a strong influence of surface roughness on the dissolution kinetics. The early stage of dissolution, where the rate was constant, was investigated for nine furosemide crystals in order to compare the initial dissolution rates for the three crystallographically unique crystal faces. In this regime the dissolution rates likely correspond to the kinetic processes at the low index faces rather than the higher index microfacets that define the pitted surface. are not truncated at the surface and in-plane interactions are strong, characteristic of a face with low surface energy, slow growth, and a large morphological importance ( Figure 5A ). In contrast, the (010) and (101) surfaces expose aminosulfonyl and carboxyl groups at the surface, thereby truncating the hydrogen-bonding network ( Figure 5B, C) . Based on this structural inspection alone, the (001) face would be expected to have a lower attachment energy than the (010) and (101) faces and should have the slowest growth rate normal to the surface, and be the slowest dissolving crystal face as well. This is consistent with the observed and calculated crystal morphology ( Figure 3 and Table 2 ), as well as the measured dissolution rates ( Table 3 ). The comparable morphological significance of (010) and (101) suggests that these surfaces have comparable growth and dissolution rates. The (101) face, however, exhibits a somewhat higher dissolution rate compared to (010), although the two are comparable within error. The corrugation of the (010) face suggests that solvent ordering or surface reconstruction may be likely, which would stabilize this face and slow its dissolution rate compared to the relatively flat (101) face. Mass transport-corrected intrinsic dissolution kinetics. FEM models were formulated for each of the nine crystals studied to obtain more insight into the dissolution kinetics, particularly the role of mass transport. These computations accounted for the experimental dissolution rate ( Table 4 (more detail is provided in Supporting
Information Table S3 ). Dislocations are recognized to be important for etch pit formation during dissolution. 74 Pitting leads to both an increase in the specific surface area and the formation of microdomains (pit walls) of higher surface energy that produces an increased dissolution rate. 70 In the case of furosemide crystals, a collection of crystals was examined by AFM before and after their immersion in aqueous solution for 10 minutes ( Figure 7 ). Prior to dissolution the (001) surfaces are largely free of defects, except for crystal C, which appears to be somewhat rough based on an AFM line profile (red line in Figure 7C ). After simultaneous immersion for 10 minutes, the crystals have dissolved, although to different extents.
Moreover, the number and depth of pits on the (001) face differ for each crystal. It can be appreciated in the images that the extent of dissolution depends on the initial crystal size, the ratio of the size of the (010) and (101) faces, and the initial surface roughness. Overall, the smaller the crystal, and the smaller the size of the (101) face in relation to the (010) face, and the rougher the crystal surface, the faster the dissolution. All these characteristics are united in crystal C which is the smallest crystal (37 µm length), has a small (101) face and the clear presence of a defect on the (001) surface (surface roughness profile in red in Figure 7 ) prior to dissolution. After 10 minutes, crystal C has dissolved by ca. 70 % from its initial volume, while the other crystals have dissolved by between 45 % and 60 %. Differences in the pitting density (surface area and roughness) are evident in the images after dissolution and the surface roughness plot in Figure 7 . The (001) surface of the dissolved crystals A and B is characterized by a smaller proportion of pits than crystals C and D. After the 10 minute dissolution period, the decrease in crystal size, as well as the roughening of the crystal faces exposed to the solvent by the formation of pits and exposure of high index faces, explains the increased dissolution kinetics at longer times ( Figure 4 ). Table S1 . Crystallographic parameters of furosemide Polymorph I Figure S1 . Calculated and experimental PXRD patterns of furosemide form I Table S2 . Comparison of the optimized furosemide unit cell parameters and single crystal CCD X-ray diffraction data Figure S2 . UV-Vis spectra of furosemide dissolved in water at different concentrations Close to diffusion control 
